JAK Inhibition in Juvenile Idiopathic Arthritis (JIA): Better Understanding of a Promising Therapy for Refractory Cases

Juvenile idiopathic arthritis (JIA) is a heterogeneous group of diseases with probably differential underlying physiopathology. Despite the revolutionary era of biologics, some patients remain difficult to treat because of disease severity, drug adverse events, drug allergy or association with sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Melki, Isabelle, Frémond, Marie-Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381267/
https://www.ncbi.nlm.nih.gov/pubmed/37510809
http://dx.doi.org/10.3390/jcm12144695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381267/
https://www.ncbi.nlm.nih.gov/pubmed/37510809
http://dx.doi.org/10.3390/jcm12144695

Ejemplares similares